Adtalem Global Education (NYSE:CVSA) CFO Robert Phelan Sells 2,414 Shares

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,414 shares of the stock in a transaction that occurred on Wednesday, July 8th. The shares were sold at an average price of $135.39, for a total value of $326,831.46. Following the transaction, the chief financial officer owned 50,492 shares in the company, valued at approximately $6,836,111.88. This trade represents a 4.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Up 0.2%

NYSE:CVSA opened at $131.17 on Friday. The company has a 50 day moving average price of $124.40. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26. The company has a market capitalization of $4.46 billion, a price-to-earnings ratio of 20.43, a price-to-earnings-growth ratio of 0.99 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million during the quarter. During the same period in the prior year, the company posted $1.92 earnings per share. Adtalem Global Education’s quarterly revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Research analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CVSA. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Truist Financial increased their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Finally, Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.